Status: 09/02/2022 12:58 p.m
The Körber European Science Prize, worth one million euros, was awarded to cell biologist Anthony Hyman, who conducts research in Dresden, on Friday in Hamburg City Hall. The Brit is honored for basic research on neurodegenerative diseases such as Alzheimer’s.
Hyman’s research on tiny cell droplets gives new hope to patients with nervous system disorders. In certain cases, these so-called condensates can attack nerve cells and trigger diseases such as Alzheimer’s. These findings offer new approaches for therapies and drugs.
“Much of my team’s work focuses on applying physical chemistry methods to understand how cellular processes fail in disease,” Hyman said. With the award he wants to further advance his research.
“Search for new drugs”
“By researching condensates, we can now search more specifically for new drugs for diseases such as ALS or Alzheimer’s,” said Senator for Science Katharina Fegebank (Greens) at the award ceremony in the large ballroom of the town hall. Hyman’s work impressively shows that research with a spirit of research and interdisciplinary exchange can also open up the previously unthinkable.
chance for a Nobel Prize
Hyman, 60, was born in the Israeli city of Haifa. The cell biologist studied zoology at the University of Cambridge in England and moved to Heidelberg in 1993. In 1999 he co-founded the Max Planck Institute for Molecular Cell Biology and Genetics in Dresden, which he still heads today. Hyman is also a member of the National Academy of Sciences Leopoldina. He teaches and researches worldwide. The chances of a Nobel Prize are not bad. So far, seven winners of the Körber Prize have received this.
Further information